gptkbp:instanceOf
|
Cannabis
psychoactive compound
|
gptkbp:actsOn
|
gptkb:CB1_receptor
gptkb:CB2_receptor
|
gptkbp:boilingPoint
|
157°C
|
gptkbp:broadcastOn
|
gptkb:Schedule_I_(US_federal_law)
|
gptkbp:CASNumber
|
1972-08-3
|
gptkbp:category
|
recreational drug
metabolite
phytocannabinoid
terpenophenolic compound
|
gptkbp:chemicalFormula
|
C21H30O2
|
gptkbp:color
|
colorless oil
|
gptkbp:discoveredBy
|
gptkb:Raphael_Mechoulam
|
gptkbp:discoveredIn
|
1964
|
gptkbp:effect
|
euphoria
altered perception
increased appetite
|
gptkbp:foundIn
|
Cannabis
|
https://www.w3.org/2000/01/rdf-schema#label
|
Δ9-THC
|
gptkbp:IUPACName
|
gptkb:(−)-trans-Δ⁹-tetrahydrocannabinol
|
gptkbp:legalStatus
|
varies by country
|
gptkbp:meltingPoint
|
157°C
|
gptkbp:metabolism
|
gptkb:11-hydroxy-THC
gptkb:THC-COOH
liver
|
gptkbp:molecularWeight
|
314.464 g/mol
|
gptkbp:notableProduct
|
gptkb:Sativex
gptkb:Marinol
|
gptkbp:routeOfAdministration
|
oral
topical
inhalation
sublingual
|
gptkbp:sideEffect
|
anxiety
paranoia
red eyes
dry mouth
impaired memory
|
gptkbp:solubility
|
lipid-soluble
|
gptkbp:synonym
|
gptkb:delta-9-tetrahydrocannabinol
gptkb:THC
gptkb:Δ9-tetrahydrocannabinol
|
gptkbp:usedFor
|
pain relief
medical marijuana
antiemetic
appetite stimulation
|
gptkbp:bfsParent
|
gptkb:Δ8-THC
|
gptkbp:bfsLayer
|
7
|